# Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/grandfathering-policy-for-packages-and-homogenous-cases-of-product-without-a-product-identifier/6ebf451c-99b2-45bb-bcb8-31ab0526d0ca

> FDA guidance document: Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier. Issue date: September 19, 2018. Get complete insights and analysis.

---

## Details

- Title: Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-09-19
- Last Changed: 2018-12-01

## Related Documents

- [Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/product-identifier-requirements-under-the-drug-supply-chain-security-act-compliance-policy-guidance-for-industry/610cbeb8-d9d2-45ae-8410-67587f5666eb)
- [Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/verification-systems-under-the-drug-supply-chain-security-act-for-certain-prescription-drugs-guidance-for-industry/78f63573-4158-4893-a86a-0ef80badd99f)
- [Drug Product Tracing: The Effect of Section 585 of the FD&C Act](https://www.globalkeysolutions.net/guidances/guidance-document/drug-product-tracing-the-effect-of-section-585-of-the-fdc-act/34847c6a-61d4-4e1e-838f-dad6e160e8c3)